Joshua Jennings
Stock Analyst at TD Cowen
(3.49)
# 931
Out of 4,711 analysts
66
Total ratings
45.9%
Success rate
6.53%
Average return
Main Sectors:
Stocks Rated by Joshua Jennings
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $100 → $110 | $88.95 | +23.66% | 7 | Dec 12, 2024 | |
| CBLL CeriBell | Maintains: Buy | $31 → $36 | $26.92 | +33.73% | 2 | Dec 9, 2024 | |
| TMDX TransMedics Group | Maintains: Buy | $175 → $120 | $61.70 | +94.49% | 9 | Nov 18, 2024 | |
| HUMA Humacyte | Reiterates: Buy | $10 | $4.64 | +115.52% | 2 | Oct 18, 2024 | |
| ALUR Allurion Technologies | Initiates: Buy | $2 | $0.35 | +474.71% | 1 | Oct 2, 2024 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $75 → $99 | $81.17 | +21.97% | 3 | Sep 16, 2024 | |
| ZBH Zimmer Biomet Holdings | Maintains: Hold | $143 → $119 | $107.12 | +11.09% | 1 | Sep 6, 2024 | |
| VCEL Vericel | Maintains: Buy | $55 → $60 | $56.50 | +6.19% | 2 | Aug 27, 2024 | |
| AIG American International Group | Maintains: Hold | $83 → $80 | $72.69 | +10.06% | 1 | Aug 13, 2024 | |
| OM Outset Medical | Maintains: Buy | $9 → $3 | $1.21 | +147.93% | 3 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $100 → $70 | $74.81 | -6.43% | 1 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $195 → $185 | $144.47 | +28.05% | 1 | Jul 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $40 | $29.50 | +35.59% | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $365 → $400 | $364.60 | +9.71% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $50 → $60 | $40.01 | +49.96% | 4 | Mar 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $52 → $34 | $35.91 | -5.32% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $14 → $18 | $7.25 | +148.28% | 3 | May 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $114 → $125 | $80.04 | +56.17% | 1 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $6 → $25 | $16.49 | +51.61% | 1 | Dec 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $130 | $114.23 | +13.81% | 9 | Dec 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7 → $5 | $2.31 | +116.45% | 1 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $125 → $117 | $81.03 | +44.39% | 3 | May 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $450 | $12.00 | +3,650.00% | 1 | Dec 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $12 | $9.35 | +28.34% | 1 | Sep 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $306 → $275 | $227.68 | +20.78% | 1 | Feb 7, 2020 |
Boston Scientific
Dec 12, 2024
Maintains: Buy
Price Target: $100 → $110
Current: $88.95
Upside: +23.66%
CeriBell
Dec 9, 2024
Maintains: Buy
Price Target: $31 → $36
Current: $26.92
Upside: +33.73%
TransMedics Group
Nov 18, 2024
Maintains: Buy
Price Target: $175 → $120
Current: $61.70
Upside: +94.49%
Humacyte
Oct 18, 2024
Reiterates: Buy
Price Target: $10
Current: $4.64
Upside: +115.52%
Allurion Technologies
Oct 2, 2024
Initiates: Buy
Price Target: $2
Current: $0.35
Upside: +474.71%
PROCEPT BioRobotics
Sep 16, 2024
Maintains: Buy
Price Target: $75 → $99
Current: $81.17
Upside: +21.97%
Zimmer Biomet Holdings
Sep 6, 2024
Maintains: Hold
Price Target: $143 → $119
Current: $107.12
Upside: +11.09%
Vericel
Aug 27, 2024
Maintains: Buy
Price Target: $55 → $60
Current: $56.50
Upside: +6.19%
American International Group
Aug 13, 2024
Maintains: Hold
Price Target: $83 → $80
Current: $72.69
Upside: +10.06%
Outset Medical
Aug 8, 2024
Maintains: Buy
Price Target: $9 → $3
Current: $1.21
Upside: +147.93%
Jul 25, 2024
Downgrades: Hold
Price Target: $100 → $70
Current: $74.81
Upside: -6.43%
Jul 18, 2024
Maintains: Buy
Price Target: $195 → $185
Current: $144.47
Upside: +28.05%
May 10, 2024
Downgrades: Hold
Price Target: $40
Current: $29.50
Upside: +35.59%
Apr 11, 2024
Maintains: Buy
Price Target: $365 → $400
Current: $364.60
Upside: +9.71%
Mar 12, 2024
Maintains: Outperform
Price Target: $50 → $60
Current: $40.01
Upside: +49.96%
Aug 4, 2023
Maintains: Outperform
Price Target: $52 → $34
Current: $35.91
Upside: -5.32%
May 11, 2023
Maintains: Outperform
Price Target: $14 → $18
Current: $7.25
Upside: +148.28%
Feb 10, 2023
Maintains: Outperform
Price Target: $114 → $125
Current: $80.04
Upside: +56.17%
Dec 30, 2022
Maintains: Outperform
Price Target: $6 → $25
Current: $16.49
Upside: +51.61%
Dec 13, 2022
Maintains: Outperform
Price Target: $130
Current: $114.23
Upside: +13.81%
Nov 11, 2022
Maintains: Outperform
Price Target: $7 → $5
Current: $2.31
Upside: +116.45%
May 27, 2022
Maintains: Outperform
Price Target: $125 → $117
Current: $81.03
Upside: +44.39%
Dec 7, 2021
Initiates: Outperform
Price Target: $450
Current: $12.00
Upside: +3,650.00%
Sep 3, 2020
Initiates: Outperform
Price Target: $12
Current: $9.35
Upside: +28.34%
Feb 7, 2020
Downgrades: Market Perform
Price Target: $306 → $275
Current: $227.68
Upside: +20.78%